Triamterene And Hydrochlorothiazide Capsule
Product Images NDC 70771-1474

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 70771-1474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 01)

Chemical structure of Triamterene and Hydrochlorothiazide, showing a benzene ring substituted with sulfonamide, chloride, and other functional groups characteristic of the compound's molecular framework.*

FDA Label Image

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 02)

Chemical structure diagram of the active ingredient Triamterene, showing its molecular framework with nitrogen and amine groups attached to a fused bicyclic ring system and a phenyl group.*

FDA Label Image

Image (Dfaa6d55 C7c2 4ab0 9a48 90146c32f665 03)

Label for Triamterene and Hydrochlorothiazide Capsules, USP 37.5 mg/25 mg, oral dosage form. The label indicates a package containing 100 capsules. Manufactured by Cadila Healthcare Ltd., India and distributed by Viona. It includes dosage strength, storage instructions, and a barcode with the NDC 70771-1474-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.